Skip to main content
. 2017 Oct 30;8(58):98931–98944. doi: 10.18632/oncotarget.22131

Table 2. Cluster differentiation genes that are downregulated in MMC compared with normal BMPC.

Probeset Gene Ratio FDR Affymetrix description
215049_x_at CD163 0.16 0.00 CD163 molecule
206398_s_at CD19 0.32 0.00 CD19 molecule
216379_x_at CD24 0.40 0.00 CD24 molecule
228766_at CD36 0.22 0.00 CD36 molecule (thrombospondin receptor)
34210_at CD52 0.28 0.00 CD52 molecule
206680_at CD5L 0.25 0.00 CD5 molecule-like
203507_at CD68 0.27 0.00 CD68 molecule /// small nucleolar RNA, H/ACA box 67
205049_s_at CD79a 0.37 0.00 CD79a molecule, immunoglobulin-associated alpha
207176_s_at CD80 0.47 0.00 CD80 molecule
200675_at CD81 0.29 0.00 CD81 molecule
203904_x_at CD82 0.23 0.00 CD82 molecule
205988_at CD84 0.43 0.00 CD84 molecule
201029_s_at CD99 0.37 0.00 CD99 molecule
204007_at FCGR3b 0.42 0.00 Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
213475_s_at ITGAL 0.47 0.00 integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
206150_at TNFRSF7 0.25 0.00 CD27 molecule

Gene expression was profiled in MMC samples from the HM cohort (n=206 patients with MM) and BMPC samples (healthy controls; n=7) using Affymetrix U133 plus 2.0 microarrays. Genes that are significantly differentially expressed were identified using SAM supervised unpaired analysis with a 5% false discovery rate.